Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Insulin resistance among HIV-infected patients: unraveling the mechanism.

Hadigan C.

Clin Infect Dis. 2005 Nov 1;41(9):1341-2. Epub 2005 Sep 29. No abstract available.

PMID:
16206113
2.

[Prevalence of mutations of resistance to HIV-I reverse transcriptase inhibitors among HIV-infected patients in the Southern Federal District].

Shemshura AB, Poddubskaia SIu, Svechnikova LV, Saukhat SR, Pazilin AS, Garaev MM.

Klin Lab Diagn. 2007 Jan;(1):42-7. Russian.

PMID:
17385442
3.

Nonnucleotide reverse-transcriptase inhibitors and treatment interruption.

DiNubile MJ.

Clin Infect Dis. 2008 Dec 15;47(12):1602; author reply 1603. doi: 10.1086/593361. No abstract available.

PMID:
19025367
4.

Liver triglyceride content in HIV-1-infected patients on combination antiretroviral therapy studied with 1H-MR spectroscopy.

Moreno-Torres A, Domingo P, Pujol J, Blanco-Vaca F, Arroyo JA, Sambeat MA.

Antivir Ther. 2007;12(2):195-203.

PMID:
17503662
5.

Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails.

Sungkanuparph S, Manosuthi W, Kiertiburanakul S, Piyavong B, Chumpathat N, Chantratita W.

Clin Infect Dis. 2007 Feb 1;44(3):447-52. Epub 2006 Dec 27.

PMID:
17205457
6.

A new insertion in the HIV-1 reverse transcriptase gene inducing major resistance to non-nucleoside reverse transcriptase inhibitors.

Amiel C, Desire N, Schneider V, Delphin N, Race E, Clavel F, Piolot T, Dam E, Rozenbaum W, Nicolas JC.

AIDS. 2005 Nov 4;19(16):1922-4.

PMID:
16227805
7.

Emerging reverse transcriptase inhibitors for the treatment of HIV infection in adults.

Fortin C, Joly V, Yeni P.

Expert Opin Emerg Drugs. 2006 May;11(2):217-30. Review.

PMID:
16634698
8.

Compilation and prevalence of mutations associated with resistance to non-nucleoside reverse transcriptase inhibitors.

Tambuyzer L, Azijn H, Rimsky LT, Vingerhoets J, Lecocq P, Kraus G, Picchio G, de Béthune MP.

Antivir Ther. 2009;14(1):103-9.

PMID:
19320243
9.

Update on primary HIV-1 resistance in Argentina: emergence of mutations conferring high-level resistance to nonnucleoside reverse transcriptase inhibitors in drug-naive patients.

Petroni A, Deluchi G, Pryluka D, Rotryng F, Bortolozzi R, Lopardo G, Bouzas MB, Zapiola I, Garone D, Rodríguez C, Chiocconi E, Lázaro ME, Murano F, Maranzana A, Oliva SM, Aparicio M, Beltrán M, Benetucci JA.

J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):506-10.

PMID:
16773027
10.

Inhibitors of HIV-1 reverse transcriptase.

Ilina T, Parniak MA.

Adv Pharmacol. 2008;56:121-67. Review. No abstract available.

PMID:
18086411
11.

Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children.

Delaugerre C, Warszawski J, Chaix ML, Veber F, Macassa E, Buseyne F, Rouzioux C, Blanche S.

J Med Virol. 2007 Sep;79(9):1261-9.

PMID:
17607781
12.

Low prevalence of insulin resistance among HIV-infected children receiving nonnucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thailand.

Lee B, Aurpibul L, Sirisanthana V, Mangklabruks A, Sirisanthana T, Puthanakit T.

HIV Med. 2009 Feb;10(2):72-8. doi: 10.1111/j.1468-1293.2008.00653.x. Epub 2008 Nov 10.

13.

Rapid accumulation of nonnucleoside reverse transcriptase inhibitor-associated resistance: evidence of transmitted resistance in rural South Africa.

Barth RE, Wensing AM, Tempelman HA, Moraba R, Schuurman R, Hoepelman AI.

AIDS. 2008 Oct 18;22(16):2210-2. doi: 10.1097/QAD.0b013e328313bf87.

PMID:
18832885
15.

A rare HIV reverse transcriptase mutation, K65N, confers reduced susceptibility to tenofovir, lamivudine and didanosine.

Ross LL, Dretler R, Gerondelis P, Rouse EG, Lim ML, Lanier ER.

AIDS. 2006 Mar 21;20(5):787-9. No abstract available.

PMID:
16514317
16.
17.

Altered hepatic expression of SREBP-1 and PPARgamma is associated with liver injury in insulin-resistant lipodystrophic HIV-infected patients.

Lemoine M, Barbu V, Girard PM, Kim M, Bastard JP, Wendum D, Paye F, Housset C, Capeau J, Serfaty L.

AIDS. 2006 Feb 14;20(3):387-95.

PMID:
16439872
18.

HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.

Martinez-Picado J, Martínez MA.

Virus Res. 2008 Jun;134(1-2):104-23. doi: 10.1016/j.virusres.2007.12.021. Epub 2008 Mar 4. Review.

PMID:
18289713
19.
20.

HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.

Sungkanuparph S, Apiwattanakul N, Thitithanyanont A, Chantratita W, Sirinavin S.

Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):83-8.

PMID:
19323038

Supplemental Content

Support Center